CGFEF yields 166666.67% · PFE yields 6.13%● Live data
📍 CGFEF pulled ahead of the other in Year 1
Combined, CGFEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CGFEF + PFE for your $10,000?
CF Energy Corp. operates as an integrated energy provider and natural gas distribution company in the People's Republic of China. The company operates through Gas Distribution Utility, Integrated Smart Energy, and Smart Mobility segments. It distributes natural gas to industrial, commercial, and residential users; offers natural gas pipeline installation and connection services; and operates two natural gas refueling stations in Sanya city, Hainan Province and Changsha city, Hunan Province that provide refueling services for vehicles, such as household cars, taxicabs, buses, and trucks. The company also transports natural gas through its 2.0 kilometers of pipeline; and develops the Haitang Bay integrated smart energy and the Meishan integrated district energy distribution projects, which uses various clean energy sources, including solar, hydro, electricity, and natural gas to supply cooling, heating, as well as hot water. In addition, it provides electric vehicle battery swap services; construction and warehousing; and charity services. The company was formerly known as Changfeng Energy Inc. and changed its name to CF Energy Corp. CF Energy Corp. was founded in 1995 and is headquartered in Markham, Canada.
Full CGFEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.